Form 4: Zimmer Biomet Director Arthur J. Higgins Reports Acquisition of Phantom Stock Units

Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.

Summary

• Arthur J. Higgins, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of phantom stock units on March 31, 2025.
• The transaction involved 244.423 phantom stock units acquired under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The price of the phantom stock units was $112.51.
• These units will be settled in cash in ten annual installments after Higgins' service as a director ends.
• Following the reported transaction, Higgins beneficially owns 34,014.071 shares of common stock, including 72.913 phantom stock units accrued on January 31, 2025, under the dividend reinvestment provision of the plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director increasing their stake in the company through a standard compensation plan.

Positives

• The acquisition of phantom stock units by a director signals confidence in the company's future performance.

Future Outlook

The phantom stock units will be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's increased stake in the company, which can be viewed positively by investors.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence.

Key Dates

Keywords

Zimmer Biomet, Director, Phantom Stock Units, Deferred Compensation Plan, Beneficial Ownership, Form 4, Higgins, ZBH